Dr. Roni Tamari, MD

Claim this profile

Memorial Sloan Kettering Cancer Center

Studies Adult T-Cell Leukemia/Lymphoma

Studies Hematologic Malignancies

10 reported clinical trials

16 drugs studied

Area of expertise

1Adult T-Cell Leukemia/Lymphoma

Roni Tamari, MD has run 5 trials for Adult T-Cell Leukemia/Lymphoma. Some of their research focus areas include:

CD33 positive

HLA-A positive

HLA-A negative

2Hematologic Malignancies

Roni Tamari, MD has run 4 trials for Hematologic Malignancies. Some of their research focus areas include:

Stage I

Stage II

Chromosome 7 abnormality positive

Affiliated Hospitals

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Monmouth (Limited Protocol Activities)

Clinical Trials Roni Tamari, MD is currently running

More about Roni Tamari, MD

Clinical Trial Related6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Roni Tamari, MD has experience with

Allogeneic Hematopoietic Stem Cell Transplantation
Orca-T
Plerixafor
Fludarabine
Busulfan
Melphalan

Breakdown of trials Roni Tamari, MD has run

Adult T-Cell Leukemia/Lymphoma

Hematologic Malignancies

Acute Myeloid Leukemia

Acute Leukemia

Myeloid Leukemia

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

What does Roni Tamari, MD specialize in?

Roni Tamari, MD focuses on Adult T-Cell Leukemia/Lymphoma and Hematologic Malignancies. In particular, much of their work with Adult T-Cell Leukemia/Lymphoma has involved CD33 positive patients, or patients who are HLA-A positive.

Is Roni Tamari, MD currently recruiting for clinical trials?

Yes, Roni Tamari, MD is currently recruiting for 1 clinical trial in New York New York. If you're interested in participating, you should apply.

Are there any treatments that Roni Tamari, MD has studied deeply?

Yes, Roni Tamari, MD has studied treatments such as Allogeneic Hematopoietic Stem Cell Transplantation, Orca-T, Plerixafor.

What is the best way to schedule an appointment with Roni Tamari, MD?

Apply for one of the trials that Roni Tamari, MD is conducting.

What is the office address of Roni Tamari, MD?

The office of Roni Tamari, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.

Is there any support for travel costs?

The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.

Top trials Roni Tamari, MD is currently running

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

1045 Sansome St, Suite 321, San Francisco, CA

hello@withpower.com (415) 900-4227

Directories

Locations

Psychology Related

Treatments

Cities

···

Dr. Roni Tamari, MD

Memorial Sloan Kettering Cancer Center

Area of expertise

Affiliated Hospitals

Clinical Trials Roni Tamari, MD is currently running

More about Roni Tamari, MD

Other Doctors you might be interested in

Frequently asked questions

Personalize Your Experience

Save Your Preferences

Understand How the Site Is Used

Dr. Roni Tamari, MD

Memorial Sloan Kettering Cancer Center

Area of expertise

Affiliated Hospitals

Clinical Trials Roni Tamari, MD is currently running

Azacitidine + Venetoclax vs Stem Cell Transplant

for Acute Myeloid Leukemia

The researchers are doing this study to find out if an allogeneic hematopoietic stem cell transplant (HSCT) or maintenance therapy with azacitidine and venetoclax is more effective at keeping AML from coming back (relapsing).

More about Roni Tamari, MD

Other Doctors you might be interested in

Frequently asked questions